Due to haemorrhagic complications of ITP at the age of 15 years presented with bleeding into cavernomas together with haematuria, romiplostim (fusion thrombopoietin peptide analogue) was administered. The gene discussed is THPO; the disease is autoimmune thrombocytopenic purpura.